# Nebulized Aztreonam for Prevention of Gram Negative Ventilator-associated Pneumonia

> **NCT03749226** · PHASE2,PHASE3 · TERMINATED · sponsor: **Hospital Universitari Joan XXIII de Tarragona.** · enrollment: 9 (actual)

## Conditions studied

- Ventilator Associated Pneumonia
- Prevention
- Respiratory Infection Other

## Interventions

- **DRUG:** Aztreonam lysine
- **DEVICE:** Aerogen Solo
- **DEVICE:** CombiHaler

## Key facts

- **NCT ID:** NCT03749226
- **Lead sponsor:** Hospital Universitari Joan XXIII de Tarragona.
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-19
- **Primary completion:** 2019-09-04
- **Final completion:** 2019-12-31
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** due to COVID-19 pandemia
- **Last updated:** 2021-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03749226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03749226, "Nebulized Aztreonam for Prevention of Gram Negative Ventilator-associated Pneumonia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03749226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*